Mark Anderson

机构：Abbott (United Kingdom)

发表论文 51 篇 · 总被引 469 次 · h-index 12

代表论文

• HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection (2022 · Hepatology Communications · 被引 17)
• Measuring hepatitis B pgRNA stability using an updated automated HBV pgRNA assay with increased sensitivity (2023 · Hepatology Communications · 被引 16)
• Correlation of Binding and Neutralizing Antibodies against SARS-CoV-2 Omicron Variant in Infection-Naïve and Convalescent BNT162b2 Recipients (2022 · Vaccines · 被引 14)
• Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G (2022 · The Journal of Infectious Diseases · 被引 12)
• Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals (2022 · The Journal of Infectious Diseases · 被引 9)
• Development and Validation of Three Automated High-Throughput Molecular Tests to Detect Monkeypox Virus Infections (2023 · The Journal of Infectious Diseases · 被引 8)